Blogs & Articles

Selecting GxP software isn’t just about features—it’s about trust, compliance, and risk. This practical framework helps life sciences organizations evaluate supplier quality, system risk, and validation needs using a structured, risk-based approach to ensure regulatory alignment and business continuity

Stay updated with the latest in the life sciences industry through these top 10 trusted information sources. From regulatory updates by the FDA and EMA to expert insights from The Scientist and Life Science Leader, this curated list helps professionals in biotech, pharma, and clinical research stay compliant, informed, and competitive. Perfect for life sciences experts in North America and Europe seeking reliable, free, and up-to-date content.

The PIC/S Guidance on Remote Assessments, formalizes remote GMP inspections, marking a shift toward digital compliance. With a risk-based approach, clear documentation, and virtual audit readiness now critical, pharmaceutical companies must align their quality systems to meet evolving regulatory expectations. Embracing remote GMP inspections is key to maintaining compliance and gaining a competitive edge.

Rethink GMP: Cut complexity, not quality. Focus on efficient systems that truly improve product quality and patient safety.

The CRIMES Framework, developed by InnovX, is designed to facilitate a thorough evaluation of potential IT investments across various dimens

Explores the validation scope outlined in the FDA's guidance, reviews key recommendations, and examines its potential impact.

As we approach 2025, QA and validation teams in life sciences must navigate emerging challenges and opportunities to remain compliant.

Life sciences focus on cybersecurity, AI, and IT alignment in 2025. QA experts lead compliance, innovation, and operational success.

10 essential questions to ask before choosing a GxP system to ensure compliance, reliability, and scalability in life sciences.